APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Herpersvirus 5 (HHV-5) Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Human Herpersvirus 5 (HHV-5) Drug Industry Growth and Trends Forecast to 2032

22 December 2025108 pages

Choose your research edition.

Industry ResearchHuman Herpersvirus 5 (HHV-5) Drug Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Herpersvirus 5 (HHV-5) Drug Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Human Herpersvirus 5 (HHV-5) Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Herpersvirus 5 (HHV-5) Drug Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Herpersvirus 5 (HHV-5) Drug Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Human Herpersvirus 5 (HHV-5) Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Human Herpersvirus 5 (HHV-5) Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Human Herpersvirus 5 (HHV-5) Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Human Herpersvirus 5 (HHV-5) Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Human Herpersvirus 5 (HHV-5) Drug include Chongqing Fu'an Pharmaceutical, Yangtze River Pharmaceutical, Wuhan Hualong, Sichuan Cologne Pharmaceutical, Shandong Luo Xin Pharmaceutical, Roche, Qianjiang Pharmaceuticals, GlaxoSmithKline and Upright and clear, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Human Herpersvirus 5 (HHV-5) Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Human Herpersvirus 5 (HHV-5) Drug market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Human Herpersvirus 5 (HHV-5) Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Human Herpersvirus 5 (HHV-5) Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Human Herpersvirus 5 (HHV-5) Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Human Herpersvirus 5 (HHV-5) Drug Market by Company

Chongqing Fu'an Pharmaceutical

Yangtze River Pharmaceutical

Wuhan Hualong

Sichuan Cologne Pharmaceutical

Shandong Luo Xin Pharmaceutical

Roche

Qianjiang Pharmaceuticals

GlaxoSmithKline

Upright and clear

On the drug new Asia

Livzon Pharmaceuticals

Hubei Branch benefits medicine

Haikou Kellett

Chongqing Winbond (acquisition of Sichuan Mingxin)

Human Herpersvirus 5 (HHV-5) Drug Segment by Type

Valerian Gilivir Drugs

Foscarnet Sodium Drugs

Ganciclovir

Valacyclovir Drugs

Acyclovir Drugs

Human Herpersvirus 5 (HHV-5) Drug Segment by Application

Organ Transplant Crowd

Immunodeficiency Crowd

CMV Herpes Crowd

Human Herpersvirus 5 (HHV-5) Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Herpersvirus 5 (HHV-5) Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Herpersvirus 5 (HHV-5) Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Herpersvirus 5 (HHV-5) Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Human Herpersvirus 5 (HHV-5) Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Human Herpersvirus 5 (HHV-5) Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Valerian Gilivir Drugs Table 2. Major Company of Foscarnet Sodium Drugs Table 3. Major Company of Ganciclovir Table 4. Major Company of Valacyclovir Drugs Table 5. Major Company of Acyclovir Drugs Table 6. Global Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2021-2026) & (k units) Table 8. Global Human Herpersvirus 5 (HHV-5) Drug Sales Market Share in Volume by Type (2021-2026) Table 9. Global Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2021-2026) & (US$ Million) Table 10. Global Human Herpersvirus 5 (HHV-5) Drug Sales Market Share in Value by Type (2021-2026) Table 11. Global Human Herpersvirus 5 (HHV-5) Drug Price by Type (2021-2026) & (US$/unit) Table 12. Global Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2027-2032) & (k units) Table 13. Global Human Herpersvirus 5 (HHV-5) Drug Sales Market Share in Volume by Type (2027-2032) Table 14. Global Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2027-2032) & (US$ Million) Table 15. Global Human Herpersvirus 5 (HHV-5) Drug Sales Market Share in Value by Type (2027-2032) Table 16. Global Human Herpersvirus 5 (HHV-5) Drug Price by Type (2027-2032) & (US$/unit) Table 17. North America Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2021-2026) & (k units) Table 18. North America Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2021-2026) & (k units) Table 20. Europe Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2021-2026) & (k units) Table 22. Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2021-2026) & (k units) Table 24. Latin America Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2021-2026) & (k units) Table 26. Middle East and Africa Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2021-2026) & (US$ Million) Table 27. Human Herpersvirus 5 (HHV-5) Drug Industry Trends Table 28. Human Herpersvirus 5 (HHV-5) Drug Industry Drivers Table 29. Human Herpersvirus 5 (HHV-5) Drug Industry Opportunities and Challenges Table 30. Human Herpersvirus 5 (HHV-5) Drug Industry Restraints Table 31. Global Human Herpersvirus 5 (HHV-5) Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Company (2021-2026) Table 33. Global Human Herpersvirus 5 (HHV-5) Drug Sales by Company (2021-2026) & (k units) Table 34. Global Human Herpersvirus 5 (HHV-5) Drug Sales Share by Company (2021-2026) Table 35. Global Human Herpersvirus 5 (HHV-5) Drug Market Price by Company (2021-2026) & (US$/unit) Table 36. Global Human Herpersvirus 5 (HHV-5) Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Human Herpersvirus 5 (HHV-5) Drug Major Company Production Sites and Headquarters Table 38. Global Human Herpersvirus 5 (HHV-5) Drug Company, Product Type & Application Table 39. Global Human Herpersvirus 5 (HHV-5) Drug Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Human Herpersvirus 5 (HHV-5) Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Human Herpersvirus 5 (HHV-5) Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Human Herpersvirus 5 (HHV-5) Drug Sales by Region (2021-2026) & (k units) Table 44. Global Human Herpersvirus 5 (HHV-5) Drug Sales Market Share in Volume by Region (2021-2026) Table 45. Global Human Herpersvirus 5 (HHV-5) Drug Sales by Region (2021-2026) & (US$ Million) Table 46. Global Human Herpersvirus 5 (HHV-5) Drug Sales Market Share in Value by Region (2021-2026) Table 47. Global Human Herpersvirus 5 (HHV-5) Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 48. Global Human Herpersvirus 5 (HHV-5) Drug Sales by Region (2027-2032) & (k units) Table 49. Global Human Herpersvirus 5 (HHV-5) Drug Sales Market Share in Volume by Region (2027-2032) Table 50. Global Human Herpersvirus 5 (HHV-5) Drug Sales by Region (2027-2032) & (US$ Million) Table 51. Global Human Herpersvirus 5 (HHV-5) Drug Sales Market Share in Value by Region (2027-2032) Table 52. Global Human Herpersvirus 5 (HHV-5) Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 53. Global Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2021-2026) & (k units) Table 55. Global Human Herpersvirus 5 (HHV-5) Drug Sales Market Share in Volume by Application (2021-2026) Table 56. Global Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2021-2026) & (US$ Million) Table 57. Global Human Herpersvirus 5 (HHV-5) Drug Sales Market Share in Value by Application (2021-2026) Table 58. Global Human Herpersvirus 5 (HHV-5) Drug Price by Application (2021-2026) & (US$/unit) Table 59. Global Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2027-2032) & (k units) Table 60. Global Human Herpersvirus 5 (HHV-5) Drug Sales Market Share in Volume by Application (2027-2032) Table 61. Global Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2027-2032) & (US$ Million) Table 62. Global Human Herpersvirus 5 (HHV-5) Drug Sales Market Share in Value by Application (2027-2032) Table 63. Global Human Herpersvirus 5 (HHV-5) Drug Price by Application (2027-2032) & (US$/unit) Table 64. North America Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2021-2026) & (k units) Table 65. North America Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2021-2026) & (k units) Table 67. Europe Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2021-2026) & (k units) Table 69. Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2021-2026) & (k units) Table 71. Latin America Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2021-2026) & (k units) Table 73. Middle East and Africa Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2021-2026) & (US$ Million) Table 74. Chongqing Fu'an Pharmaceutical Company Information Table 75. Chongqing Fu'an Pharmaceutical Business Overview Table 76. Chongqing Fu'an Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Chongqing Fu'an Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Product Portfolio Table 78. Chongqing Fu'an Pharmaceutical Recent Development Table 79. Yangtze River Pharmaceutical Company Information Table 80. Yangtze River Pharmaceutical Business Overview Table 81. Yangtze River Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Yangtze River Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Product Portfolio Table 83. Yangtze River Pharmaceutical Recent Development Table 84. Wuhan Hualong Company Information Table 85. Wuhan Hualong Business Overview Table 86. Wuhan Hualong Human Herpersvirus 5 (HHV-5) Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Wuhan Hualong Human Herpersvirus 5 (HHV-5) Drug Product Portfolio Table 88. Wuhan Hualong Recent Development Table 89. Sichuan Cologne Pharmaceutical Company Information Table 90. Sichuan Cologne Pharmaceutical Business Overview Table 91. Sichuan Cologne Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Sichuan Cologne Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Product Portfolio Table 93. Sichuan Cologne Pharmaceutical Recent Development Table 94. Shandong Luo Xin Pharmaceutical Company Information Table 95. Shandong Luo Xin Pharmaceutical Business Overview Table 96. Shandong Luo Xin Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Shandong Luo Xin Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Product Portfolio Table 98. Shandong Luo Xin Pharmaceutical Recent Development Table 99. Roche Company Information Table 100. Roche Business Overview Table 101. Roche Human Herpersvirus 5 (HHV-5) Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. Roche Human Herpersvirus 5 (HHV-5) Drug Product Portfolio Table 103. Roche Recent Development Table 104. Qianjiang Pharmaceuticals Company Information Table 105. Qianjiang Pharmaceuticals Business Overview Table 106. Qianjiang Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. Qianjiang Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Product Portfolio Table 108. Qianjiang Pharmaceuticals Recent Development Table 109. GlaxoSmithKline Company Information Table 110. GlaxoSmithKline Business Overview Table 111. GlaxoSmithKline Human Herpersvirus 5 (HHV-5) Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 112. GlaxoSmithKline Human Herpersvirus 5 (HHV-5) Drug Product Portfolio Table 113. GlaxoSmithKline Recent Development Table 114. Upright and clear Company Information Table 115. Upright and clear Business Overview Table 116. Upright and clear Human Herpersvirus 5 (HHV-5) Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 117. Upright and clear Human Herpersvirus 5 (HHV-5) Drug Product Portfolio Table 118. Upright and clear Recent Development Table 119. On the drug new Asia Company Information Table 120. On the drug new Asia Business Overview Table 121. On the drug new Asia Human Herpersvirus 5 (HHV-5) Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 122. On the drug new Asia Human Herpersvirus 5 (HHV-5) Drug Product Portfolio Table 123. On the drug new Asia Recent Development Table 124. Livzon Pharmaceuticals Company Information Table 125. Livzon Pharmaceuticals Business Overview Table 126. Livzon Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 127. Livzon Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Product Portfolio Table 128. Livzon Pharmaceuticals Recent Development Table 129. Hubei Branch benefits medicine Company Information Table 130. Hubei Branch benefits medicine Business Overview Table 131. Hubei Branch benefits medicine Human Herpersvirus 5 (HHV-5) Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 132. Hubei Branch benefits medicine Human Herpersvirus 5 (HHV-5) Drug Product Portfolio Table 133. Hubei Branch benefits medicine Recent Development Table 134. Haikou Kellett Company Information Table 135. Haikou Kellett Business Overview Table 136. Haikou Kellett Human Herpersvirus 5 (HHV-5) Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 137. Haikou Kellett Human Herpersvirus 5 (HHV-5) Drug Product Portfolio Table 138. Haikou Kellett Recent Development Table 139. Chongqing Winbond (acquisition of Sichuan Mingxin) Company Information Table 140. Chongqing Winbond (acquisition of Sichuan Mingxin) Business Overview Table 141. Chongqing Winbond (acquisition of Sichuan Mingxin) Human Herpersvirus 5 (HHV-5) Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 142. Chongqing Winbond (acquisition of Sichuan Mingxin) Human Herpersvirus 5 (HHV-5) Drug Product Portfolio Table 143. Chongqing Winbond (acquisition of Sichuan Mingxin) Recent Development Table 144. North America Human Herpersvirus 5 (HHV-5) Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 145. North America Human Herpersvirus 5 (HHV-5) Drug Sales by Country (2021-2026) & (k units) Table 146. North America Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Country (2021-2026) Table 147. North America Human Herpersvirus 5 (HHV-5) Drug Sales Forecast by Country (2027-2032) & (k units) Table 148. North America Human Herpersvirus 5 (HHV-5) Drug Sales Market Share Forecast by Country (2027-2032) Table 149. North America Human Herpersvirus 5 (HHV-5) Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 150. North America Human Herpersvirus 5 (HHV-5) Drug Market Size by Country (2021-2026) & (US$ Million) Table 151. North America Human Herpersvirus 5 (HHV-5) Drug Market Share by Country (2021-2026) Table 152. North America Human Herpersvirus 5 (HHV-5) Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 153. North America Human Herpersvirus 5 (HHV-5) Drug Market Share Forecast by Country (2027-2032) Table 154. Europe Human Herpersvirus 5 (HHV-5) Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 155. Europe Human Herpersvirus 5 (HHV-5) Drug Sales by Country (2021-2026) & (k units) Table 156. Europe Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Country (2021-2026) Table 157. Europe Human Herpersvirus 5 (HHV-5) Drug Sales Forecast by Country (2027-2032) & (k units) Table 158. Europe Human Herpersvirus 5 (HHV-5) Drug Sales Market Share Forecast by Country (2027-2032) Table 159. Europe Human Herpersvirus 5 (HHV-5) Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 160. Europe Human Herpersvirus 5 (HHV-5) Drug Market Size by Country (2021-2026) & (US$ Million) Table 161. Europe Human Herpersvirus 5 (HHV-5) Drug Market Share by Country (2021-2026) Table 162. Europe Human Herpersvirus 5 (HHV-5) Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 163. Europe Human Herpersvirus 5 (HHV-5) Drug Market Share Forecast by Country (2027-2032) Table 164. Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 165. Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Sales by Country (2021-2026) & (k units) Table 166. Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Country (2021-2026) Table 167. Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Sales Forecast by Country (2027-2032) & (k units) Table 168. Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Sales Market Share Forecast by Country (2027-2032) Table 169. Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 170. Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Market Size by Country (2021-2026) & (US$ Million) Table 171. Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Market Share by Country (2021-2026) Table 172. Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 173. Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Market Share Forecast by Country (2027-2032) Table 174. Latin America Human Herpersvirus 5 (HHV-5) Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 175. Latin America Human Herpersvirus 5 (HHV-5) Drug Sales by Country (2021-2026) & (k units) Table 176. Latin America Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Country (2021-2026) Table 177. Latin America Human Herpersvirus 5 (HHV-5) Drug Sales Forecast by Country (2027-2032) & (k units) Table 178. Latin America Human Herpersvirus 5 (HHV-5) Drug Sales Market Share Forecast by Country (2027-2032) Table 179. Latin America Human Herpersvirus 5 (HHV-5) Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 180. Latin America Human Herpersvirus 5 (HHV-5) Drug Market Size by Country (2021-2026) & (US$ Million) Table 181. Latin America Human Herpersvirus 5 (HHV-5) Drug Market Share by Country (2021-2026) Table 182. Latin America Human Herpersvirus 5 (HHV-5) Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 183. Latin America Human Herpersvirus 5 (HHV-5) Drug Market Share Forecast by Country (2027-2032) Table 184. Middle East and Africa Human Herpersvirus 5 (HHV-5) Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 185. Middle East and Africa Human Herpersvirus 5 (HHV-5) Drug Sales by Country (2021-2026) & (k units) Table 186. Middle East and Africa Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Country (2021-2026) Table 187. Middle East and Africa Human Herpersvirus 5 (HHV-5) Drug Sales Forecast by Country (2027-2032) & (k units) Table 188. Middle East and Africa Human Herpersvirus 5 (HHV-5) Drug Sales Market Share Forecast by Country (2027-2032) Table 189. Middle East and Africa Human Herpersvirus 5 (HHV-5) Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 190. Middle East and Africa Human Herpersvirus 5 (HHV-5) Drug Market Size by Country (2021-2026) & (US$ Million) Table 191. Middle East and Africa Human Herpersvirus 5 (HHV-5) Drug Market Share by Country (2021-2026) Table 192. Middle East and Africa Human Herpersvirus 5 (HHV-5) Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 193. Middle East and Africa Human Herpersvirus 5 (HHV-5) Drug Market Share Forecast by Country (2027-2032) Table 194. Key Raw Materials Table 195. Raw Materials Key Suppliers Table 196. Human Herpersvirus 5 (HHV-5) Drug Distributors List Table 197. Human Herpersvirus 5 (HHV-5) Drug Customers List Table 198. Research Programs/Design for This Report Table 199. Authors List of This Report Table 200. Secondary Sources Table 201. Primary Sources List of Figures Figure 1. Human Herpersvirus 5 (HHV-5) Drug Image Figure 2. Global Human Herpersvirus 5 (HHV-5) Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Herpersvirus 5 (HHV-5) Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Human Herpersvirus 5 (HHV-5) Drug Sales (2021-2032) & (k units) Figure 5. Valerian Gilivir Drugs Image Figure 6. Global Valerian Gilivir Drugs Sales YoY Growth (2021-2032) & (k units) Figure 7. Foscarnet Sodium Drugs Image Figure 8. Global Foscarnet Sodium Drugs Sales YoY Growth (2021-2032) & (k units) Figure 9. Ganciclovir Image Figure 10. Global Ganciclovir Sales YoY Growth (2021-2032) & (k units) Figure 11. Valacyclovir Drugs Image Figure 12. Global Valacyclovir Drugs Sales YoY Growth (2021-2032) & (k units) Figure 13. Acyclovir Drugs Image Figure 14. Global Acyclovir Drugs Sales YoY Growth (2021-2032) & (k units) Figure 15. Global Human Herpersvirus 5 (HHV-5) Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Human Herpersvirus 5 (HHV-5) Drug Market Share by Type 2025 VS 2032 Figure 17. North America Human Herpersvirus 5 (HHV-5) Drug Sales Market Share in Volume by Type in 2025 Figure 18. North America Human Herpersvirus 5 (HHV-5) Drug Sales Market Share in Value by Type in 2025 Figure 19. Europe Human Herpersvirus 5 (HHV-5) Drug Sales Market Share in Volume by Type in 2025 Figure 20. Europe Human Herpersvirus 5 (HHV-5) Drug Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Sales Market Share in Value by Type in 2025 Figure 23. Latin America Human Herpersvirus 5 (HHV-5) Drug Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Human Herpersvirus 5 (HHV-5) Drug Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Human Herpersvirus 5 (HHV-5) Drug Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Human Herpersvirus 5 (HHV-5) Drug Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Human Herpersvirus 5 (HHV-5) Drug Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Organ Transplant Crowd Image Figure 30. Global Organ Transplant Crowd Sales YoY Growth (2021-2032) & (k units) Figure 31. Immunodeficiency Crowd Image Figure 32. Global Immunodeficiency Crowd Sales YoY Growth (2021-2032) & (k units) Figure 33. CMV Herpes Crowd Image Figure 34. Global CMV Herpes Crowd Sales YoY Growth (2021-2032) & (k units) Figure 35. Global Human Herpersvirus 5 (HHV-5) Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Human Herpersvirus 5 (HHV-5) Drug Market Share by Application 2025 VS 2032 Figure 37. North America Human Herpersvirus 5 (HHV-5) Drug Sales Market Share in Volume by Application in 2025 Figure 38. North America Human Herpersvirus 5 (HHV-5) Drug Sales Market Share in Value by Application in 2025 Figure 39. Europe Human Herpersvirus 5 (HHV-5) Drug Sales Market Share in Volume by Application in 2025 Figure 40. Europe Human Herpersvirus 5 (HHV-5) Drug Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Sales Market Share in Value by Application in 2025 Figure 43. Latin America Human Herpersvirus 5 (HHV-5) Drug Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Human Herpersvirus 5 (HHV-5) Drug Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Human Herpersvirus 5 (HHV-5) Drug Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Human Herpersvirus 5 (HHV-5) Drug Sales Market Share in Value by Application in 2025 Figure 47. North America Human Herpersvirus 5 (HHV-5) Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. North America Human Herpersvirus 5 (HHV-5) Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Human Herpersvirus 5 (HHV-5) Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Human Herpersvirus 5 (HHV-5) Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Human Herpersvirus 5 (HHV-5) Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Europe Human Herpersvirus 5 (HHV-5) Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Human Herpersvirus 5 (HHV-5) Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Human Herpersvirus 5 (HHV-5) Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Human Herpersvirus 5 (HHV-5) Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Latin America Human Herpersvirus 5 (HHV-5) Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Human Herpersvirus 5 (HHV-5) Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Human Herpersvirus 5 (HHV-5) Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Human Herpersvirus 5 (HHV-5) Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 64. Middle East and Africa Human Herpersvirus 5 (HHV-5) Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Human Herpersvirus 5 (HHV-5) Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Human Herpersvirus 5 (HHV-5) Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Human Herpersvirus 5 (HHV-5) Drug Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Human Herpersvirus 5 (HHV-5) Drug Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Valerian Gilivir Drugs
  • Foscarnet Sodium Drugs
  • Ganciclovir
  • Valacyclovir Drugs
  • Acyclovir Drugs
Applications
  • Organ Transplant Crowd
  • Immunodeficiency Crowd
  • CMV Herpes Crowd
Companies covered
  • Chongqing Fu'an Pharmaceutical
  • Yangtze River Pharmaceutical
  • Wuhan Hualong
  • Sichuan Cologne Pharmaceutical
  • Shandong Luo Xin Pharmaceutical
  • Roche
  • Qianjiang Pharmaceuticals
  • GlaxoSmithKline
  • Upright and clear
  • On the drug new Asia
  • Livzon Pharmaceuticals
  • Hubei Branch benefits medicine
  • Haikou Kellett
  • Chongqing Winbond (acquisition of Sichuan Mingxin)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Human Herpersvirus 5 (HHV-5) Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Human Herpersvirus 5 (HHV-5) Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Human Herpersvirus 5 (HHV-5) Drug Market by Type
  6. 1.3.1 Valerian Gilivir Drugs
  7. 1.3.2 Foscarnet Sodium Drugs
  8. 1.3.3 Ganciclovir
  9. 1.3.4 Valacyclovir Drugs
  10. 1.3.5 Acyclovir Drugs
  11. 1.4 Global Human Herpersvirus 5 (HHV-5) Drug Market Size by Type
  12. 1.4.1 Global Human Herpersvirus 5 (HHV-5) Drug Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Human Herpersvirus 5 (HHV-5) Drug Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Human Herpersvirus 5 (HHV-5) Drug Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Human Herpersvirus 5 (HHV-5) Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Human Herpersvirus 5 (HHV-5) Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Human Herpersvirus 5 (HHV-5) Drug Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Human Herpersvirus 5 (HHV-5) Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Human Herpersvirus 5 (HHV-5) Drug Industry Trends
  2. 2.2 Human Herpersvirus 5 (HHV-5) Drug Industry Drivers
  3. 2.3 Human Herpersvirus 5 (HHV-5) Drug Industry Opportunities and Challenges
  4. 2.4 Human Herpersvirus 5 (HHV-5) Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Human Herpersvirus 5 (HHV-5) Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Human Herpersvirus 5 (HHV-5) Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Human Herpersvirus 5 (HHV-5) Drug Price (2021-2026)
  4. 3.4 Global Human Herpersvirus 5 (HHV-5) Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Human Herpersvirus 5 (HHV-5) Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Human Herpersvirus 5 (HHV-5) Drug Company, Product Type & Application
  7. 3.7 Global Human Herpersvirus 5 (HHV-5) Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Human Herpersvirus 5 (HHV-5) Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Human Herpersvirus 5 (HHV-5) Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Human Herpersvirus 5 (HHV-5) Drug Tier 1, Tier 2, and Tier 3
4 Human Herpersvirus 5 (HHV-5) Drug Regional Status and Outlook
  1. 4.1 Global Human Herpersvirus 5 (HHV-5) Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Human Herpersvirus 5 (HHV-5) Drug Historic Market Size by Region
  3. 4.2.1 Global Human Herpersvirus 5 (HHV-5) Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Human Herpersvirus 5 (HHV-5) Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Human Herpersvirus 5 (HHV-5) Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Human Herpersvirus 5 (HHV-5) Drug Forecasted Market Size by Region
  7. 4.3.1 Global Human Herpersvirus 5 (HHV-5) Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Human Herpersvirus 5 (HHV-5) Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Human Herpersvirus 5 (HHV-5) Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Human Herpersvirus 5 (HHV-5) Drug by Application
  1. 5.1 Human Herpersvirus 5 (HHV-5) Drug Market by Application
  2. 5.1.1 Organ Transplant Crowd
  3. 5.1.2 Immunodeficiency Crowd
  4. 5.1.3 CMV Herpes Crowd
  5. 5.2 Global Human Herpersvirus 5 (HHV-5) Drug Market Size by Application
  6. 5.2.1 Global Human Herpersvirus 5 (HHV-5) Drug Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Human Herpersvirus 5 (HHV-5) Drug Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Human Herpersvirus 5 (HHV-5) Drug Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Human Herpersvirus 5 (HHV-5) Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Human Herpersvirus 5 (HHV-5) Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Human Herpersvirus 5 (HHV-5) Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Human Herpersvirus 5 (HHV-5) Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Chongqing Fu'an Pharmaceutical
  2. 6.1.1 Chongqing Fu'an Pharmaceutical Company Information
  3. 6.1.2 Chongqing Fu'an Pharmaceutical Business Overview
  4. 6.1.3 Chongqing Fu'an Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Chongqing Fu'an Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Product Portfolio
  6. 6.1.5 Chongqing Fu'an Pharmaceutical Recent Developments
  7. 6.2 Yangtze River Pharmaceutical
  8. 6.2.1 Yangtze River Pharmaceutical Company Information
  9. 6.2.2 Yangtze River Pharmaceutical Business Overview
  10. 6.2.3 Yangtze River Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Yangtze River Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Product Portfolio
  12. 6.2.5 Yangtze River Pharmaceutical Recent Developments
  13. 6.3 Wuhan Hualong
  14. 6.3.1 Wuhan Hualong Company Information
  15. 6.3.2 Wuhan Hualong Business Overview
  16. 6.3.3 Wuhan Hualong Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Wuhan Hualong Human Herpersvirus 5 (HHV-5) Drug Product Portfolio
  18. 6.3.5 Wuhan Hualong Recent Developments
  19. 6.4 Sichuan Cologne Pharmaceutical
  20. 6.4.1 Sichuan Cologne Pharmaceutical Company Information
  21. 6.4.2 Sichuan Cologne Pharmaceutical Business Overview
  22. 6.4.3 Sichuan Cologne Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Sichuan Cologne Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Product Portfolio
  24. 6.4.5 Sichuan Cologne Pharmaceutical Recent Developments
  25. 6.5 Shandong Luo Xin Pharmaceutical
  26. 6.5.1 Shandong Luo Xin Pharmaceutical Company Information
  27. 6.5.2 Shandong Luo Xin Pharmaceutical Business Overview
  28. 6.5.3 Shandong Luo Xin Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Shandong Luo Xin Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Product Portfolio
  30. 6.5.5 Shandong Luo Xin Pharmaceutical Recent Developments
  31. 6.6 Roche
  32. 6.6.1 Roche Company Information
  33. 6.6.2 Roche Business Overview
  34. 6.6.3 Roche Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Roche Human Herpersvirus 5 (HHV-5) Drug Product Portfolio
  36. 6.6.5 Roche Recent Developments
  37. 6.7 Qianjiang Pharmaceuticals
  38. 6.7.1 Qianjiang Pharmaceuticals Company Information
  39. 6.7.2 Qianjiang Pharmaceuticals Business Overview
  40. 6.7.3 Qianjiang Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Qianjiang Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Product Portfolio
  42. 6.7.5 Qianjiang Pharmaceuticals Recent Developments
  43. 6.8 GlaxoSmithKline
  44. 6.8.1 GlaxoSmithKline Company Information
  45. 6.8.2 GlaxoSmithKline Business Overview
  46. 6.8.3 GlaxoSmithKline Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 GlaxoSmithKline Human Herpersvirus 5 (HHV-5) Drug Product Portfolio
  48. 6.8.5 GlaxoSmithKline Recent Developments
  49. 6.9 Upright and clear
  50. 6.9.1 Upright and clear Company Information
  51. 6.9.2 Upright and clear Business Overview
  52. 6.9.3 Upright and clear Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Upright and clear Human Herpersvirus 5 (HHV-5) Drug Product Portfolio
  54. 6.9.5 Upright and clear Recent Developments
  55. 6.10 On the drug new Asia
  56. 6.10.1 On the drug new Asia Company Information
  57. 6.10.2 On the drug new Asia Business Overview
  58. 6.10.3 On the drug new Asia Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 On the drug new Asia Human Herpersvirus 5 (HHV-5) Drug Product Portfolio
  60. 6.10.5 On the drug new Asia Recent Developments
  61. 6.11 Livzon Pharmaceuticals
  62. 6.11.1 Livzon Pharmaceuticals Company Information
  63. 6.11.2 Livzon Pharmaceuticals Business Overview
  64. 6.11.3 Livzon Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Livzon Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Product Portfolio
  66. 6.11.5 Livzon Pharmaceuticals Recent Developments
  67. 6.12 Hubei Branch benefits medicine
  68. 6.12.1 Hubei Branch benefits medicine Company Information
  69. 6.12.2 Hubei Branch benefits medicine Business Overview
  70. 6.12.3 Hubei Branch benefits medicine Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Hubei Branch benefits medicine Human Herpersvirus 5 (HHV-5) Drug Product Portfolio
  72. 6.12.5 Hubei Branch benefits medicine Recent Developments
  73. 6.13 Haikou Kellett
  74. 6.13.1 Haikou Kellett Company Information
  75. 6.13.2 Haikou Kellett Business Overview
  76. 6.13.3 Haikou Kellett Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Haikou Kellett Human Herpersvirus 5 (HHV-5) Drug Product Portfolio
  78. 6.13.5 Haikou Kellett Recent Developments
  79. 6.14 Chongqing Winbond (acquisition of Sichuan Mingxin)
  80. 6.14.1 Chongqing Winbond (acquisition of Sichuan Mingxin) Company Information
  81. 6.14.2 Chongqing Winbond (acquisition of Sichuan Mingxin) Business Overview
  82. 6.14.3 Chongqing Winbond (acquisition of Sichuan Mingxin) Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Chongqing Winbond (acquisition of Sichuan Mingxin) Human Herpersvirus 5 (HHV-5) Drug Product Portfolio
  84. 6.14.5 Chongqing Winbond (acquisition of Sichuan Mingxin) Recent Developments
7 North America by Country
  1. 7.1 North America Human Herpersvirus 5 (HHV-5) Drug Sales by Country
  2. 7.1.1 North America Human Herpersvirus 5 (HHV-5) Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Human Herpersvirus 5 (HHV-5) Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Human Herpersvirus 5 (HHV-5) Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Human Herpersvirus 5 (HHV-5) Drug Market Size by Country
  6. 7.2.1 North America Human Herpersvirus 5 (HHV-5) Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Human Herpersvirus 5 (HHV-5) Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Human Herpersvirus 5 (HHV-5) Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Human Herpersvirus 5 (HHV-5) Drug Sales by Country
  2. 8.1.1 Europe Human Herpersvirus 5 (HHV-5) Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Human Herpersvirus 5 (HHV-5) Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Human Herpersvirus 5 (HHV-5) Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Human Herpersvirus 5 (HHV-5) Drug Market Size by Country
  6. 8.2.1 Europe Human Herpersvirus 5 (HHV-5) Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Human Herpersvirus 5 (HHV-5) Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Human Herpersvirus 5 (HHV-5) Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Sales by Country
  2. 9.1.1 Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Human Herpersvirus 5 (HHV-5) Drug Sales by Country
  2. 10.1.1 South America Human Herpersvirus 5 (HHV-5) Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Human Herpersvirus 5 (HHV-5) Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Human Herpersvirus 5 (HHV-5) Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Human Herpersvirus 5 (HHV-5) Drug Market Size by Country
  6. 10.2.1 South America Human Herpersvirus 5 (HHV-5) Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Human Herpersvirus 5 (HHV-5) Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Human Herpersvirus 5 (HHV-5) Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Human Herpersvirus 5 (HHV-5) Drug Sales by Country
  2. 11.1.1 Middle East and Africa Human Herpersvirus 5 (HHV-5) Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Human Herpersvirus 5 (HHV-5) Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Human Herpersvirus 5 (HHV-5) Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Human Herpersvirus 5 (HHV-5) Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Human Herpersvirus 5 (HHV-5) Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Human Herpersvirus 5 (HHV-5) Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Human Herpersvirus 5 (HHV-5) Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Human Herpersvirus 5 (HHV-5) Drug Value Chain Analysis
  2. 12.1.1 Human Herpersvirus 5 (HHV-5) Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Human Herpersvirus 5 (HHV-5) Drug Production Mode & Process
  7. 12.2 Human Herpersvirus 5 (HHV-5) Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Human Herpersvirus 5 (HHV-5) Drug Distributors
  10. 12.2.3 Human Herpersvirus 5 (HHV-5) Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst